Recent SBRA Stock Price | SBRA Stock Predictions | |
$13.70 | +12.85% |
$15.46 |
Recent SBRA Analyst Ratings Breakdown, Making SBRA Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 7 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 9 | 9 | 9 | 9 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.2 | 2.2 | 2.13 | 2.2 |
For the SBRA stock predictions from the analysts covering Sabra Health Care REIT Inc, we have collected all of the individual SBRA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 12 different analysts covering SBRA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since SBRA stock predictions may vary widely, another useful metric to consider is the median SBRA stock prediction, which represents the price at which half of the analysts
made SBRA stock predictions that were higher and half made SBRA stock predictions that were lower. This makes for a different take on the SBRA stock predictions out there, as compared to average or mean.
And that median across all the individual SBRA stock predictions was: $15.5 as of 2024-04-25.
The very highest of the SBRA stock predictions for one year price target was $21.0, while the very lowest of the SBRA stock predictions in the analyst group was
$12.5 (with a standard deviation of $2.33). Get the latest Zacks research report on SBRA — FREE
Find out: SBRA next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CNS Stock Predictions
ARVN Stock Predictions
NTR Stock Predictions
BBBY Stock Predictions
ACIW Stock Predictions
DXCM Stock Predictions
ESI Stock Predictions
MED Stock Predictions
IONS Stock Predictions
|
SBRA Next Dividend Date » (Projection based upon history) SBRA Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (2.80 out of 4) 23rd percentile
(ranked lower than approx. 77% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |